MARKET

CDNA

CDNA

Caredx
NASDAQ
19.47
+1.12
+6.10%
After Hours: 19.47 0 0.00% 19:09 02/06 EST
OPEN
18.72
PREV CLOSE
18.35
HIGH
19.67
LOW
18.41
VOLUME
878.27K
TURNOVER
--
52 WEEK HIGH
25.55
52 WEEK LOW
10.96
MARKET CAP
1.00B
P/E (TTM)
24.17
1D
5D
1M
3M
1Y
5Y
1D
Analysts Conflicted on These Healthcare Names: CareDx (CDNA) and DaVita (DVA)
TipRanks · 3d ago
CareDx kündigt Präsentation klinischer Validierungsdaten zum AlloHeme-Test zur Rückfallüberwachung bei Blutkrebspatienten an
Reuters · 3d ago
CareDx to Present AlloHeme Pivotal Clinical Validation Data for Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
Reuters · 3d ago
Weekly Report: what happened at CDNA last week (0126-0130)?
Weekly Report · 4d ago
CareDx to Participate in BTIG 13th Annual MedTech Conference
Reuters · 01/27 21:06
Weekly Report: what happened at CDNA last week (0119-0123)?
Weekly Report · 01/26 09:19
CareDx Inc. President and CEO John Walter Hanna Jr. Reports Disposal of Common Shares
Reuters · 01/23 22:58
Analysts Conflicted on These Healthcare Names: Ufp Technologies (UFPT), Eledon Pharmaceuticals (ELDN) and CareDx (CDNA)
TipRanks · 01/23 14:50
More
About CDNA
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.

Webull offers CareDx Inc stock information, including NASDAQ: CDNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDNA stock methods without spending real money on the virtual paper trading platform.